You are here:

• Home Page
• About EphMRA
• EphMRA Committees
• Databases & Systems

Databases & Systems Committee

Objectives

Ensure databases & systems provide the best suitable platform to do international secondary market research through partnership with the major global providers.

Activities

- Regular meetings with core providers IMS HEALTH & CEGEDIM STRATEGIC DATA to discuss their databases & systems offerings (quality, reliability & service associated) and main development pathways (meet business data requirements, address changing market dynamics or make the best use of latest technologies). They represent a key communication channel between global secondary data providers and international secondary market research functions from pharmaco’s

- Share experiences & best practice in international secondary pharmaceutical market research area using any type of data : sales, medical or promotional

- Identify current unmet needs of international pharmaceutical market research and share them with Syndicated Data Committee to cooperate on provider research

The Committee consists of pharmaceutical international market research representatives and IMS & CSD representatives. Project teams may be formed to address specific needs and other providers may be invited to participate whenever appropriate. The Committee always welcomes new members from pharmaceutical industry to enlarge its knowledge & experience sharing.

PATIENT DATABASES & SYSTEMS GROUP PROJECT

(** D&SC Group members)

Background : At the moment there is no offering in the market that makes patient data easily available for cross-country, cross-therapeutic area analyses to the international pharmaceutical market research professionals. Current reference offerings for other data type areas are e.g. IMS MIDAS Partner, DATAVIEW & PADDS for sales & medical data or CSD CAM REPORTIVE & IMS PADDS PROMOTRACK for promotional data

Aim : Share international pharmaceutical market research experiences & needs to cooperate with providers on such tools developments. Discuss characteristics of needed tools, be a pharma reference point & a challenger as well as beta tester during developments. The Group will look at systems holding data sourced from electronic systems (EMR - electronic medical records; claims data) and syndicated primary market research with doctors or patients. Pharma international market researchers & providers are welcome to join this Group project.